Jill M. Sturdivant

Statistics

Publications

Citations

160

H-Index

Active since

2016

Affiliations

Aerie Pharmaceuticals (United States)(Current)

Jill M. Sturdivant is an author at Aerie Pharmaceuticals (United States) specializing in inhibitor specificity, ophthalmology, and ocular drug metabolism.

ORCID

Publications per year

2016–2017

Publications

Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma

Jill M. Sturdivant, Susan M. Royalty, Cheng‐Wen Lin et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 104 citations · Full text

Medicine, Medicinal Chemistry, Ophthalmology +11

Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1′-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators

Christopher D. McCune, Matthew L. Beio, Jill M. Sturdivant et al. · Journal of the American Chemical Society · 2017 · 56 citations · Full text

Life Sciences, Biochemistry, Chemical Biology +15

1–2 of 2